RxDoctor Payments Data

James Duncan, DO

Family Medicine · West Portsmouth, OHNPI 1235216847

Payments from drug & device makers

$316in general payments, 2019–2025

Across 12 payments — averaging $26.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$100
  • AbbVie$61
  • Regeneron Healthcare Solutions, Inc.$54
  • Antares Pharma, Inc.$35
  • Hikma Pharmaceuticals USA$35
  • Indivior Inc.$16
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$18157%
  • Education$13543%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$316 in reported general payments places this provider in the 45th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$173,882
Medicare patients
219
Services billed
2,660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide82$88,855
TrulicityDulaglutide42$52,263
JardianceEmpagliflozin41$49,054
EliquisApixaban40$30,967
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$27,654
FarxigaDapagliflozin Propanediol36$25,415
Breo ElliptaFluticasone/Vilanterol41$16,380
LinzessLinaclotide17$14,782
XareltoRivaroxaban15$13,730
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog15$10,866
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl159$8,207
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$7,695
Albuterol Sulfate HfaAlbuterol Sulfate245$7,169
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen429$7,104
Potassium Chloride245$5,584

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Synthroid$61$17,74674 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone$35$8,207159 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in West Portsmouth

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →